Common use of Royalty Adjustment Clause in Contracts

Royalty Adjustment. If, in a particular country, there is no Valid Claim of an issued Patent Controlled by GSK or Controlled jointly by GSK and Anacor that [***] of the Anacor Development Compound included in the Product either at the time of First Commercial Sale or anytime thereafter, then the royalty rate to be paid by Anacor to GSK on Net Sales of such Product in such country shall be reduced as follows; provided, however , that in no event GSK shall have any obligation to pay a royalty to Anacor as provided in this Section 6.7.3 during the period that is more than ten (10) years after First Commercial Sale in such country:

Appears in 2 contracts

Samples: Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc), Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Royalty Adjustment. If, in a particular country, there is no Valid Claim of an issued Patent Controlled by GSK or Controlled jointly by GSK and Anacor that [***] of the Anacor Development Compound included in the Product either at the time of First Commercial Sale or anytime thereafter, then the royalty rate to be paid by Anacor to GSK on Net Sales of such Product in such country shall be reduced as follows[***]; provided, however however, that in no event GSK Anacor shall have any obligation to pay a royalty to Anacor GSK as provided in this Section 6.7.3 6.6.3 during the period that is more than ten (10) years after First Commercial Sale [***] in such country:.

Appears in 2 contracts

Samples: Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc), Option and License Agreement (Anacor Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Royalty Adjustment. If, in a particular country, there is no Valid Claim of an issued Patent Controlled by GSK or Controlled jointly by GSK and Anacor that [***] of the Anacor Development Compound included in the Product either at the time of First Commercial Sale or anytime thereafter, then the royalty rate to be paid by Anacor to GSK on Net Sales of such Product in such country shall be reduced as follows[***]; provided, however however, that in no event GSK Anacor shall have any obligation to pay a royalty to Anacor GSK as provided in this Section 6.7.3 6.6.3 during the period that is more than ten (10) years after First Commercial Sale in such country:.

Appears in 2 contracts

Samples: Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc), Research and Development Collaboration, Option and License Agreement (Anacor Pharmaceuticals Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.